WB

Wayne A. Border

LF La Jolla Cancer Research Foundation: 2 patents #39 of 90Top 45%
UU University Of Utah: 2 patents #44 of 382Top 15%
UU University Of Utah: 2 patents #446 of 1,848Top 25%
AC American National Red Cross: 1 patents #40 of 100Top 40%
TI The Burnham Institute: 1 patents #44 of 117Top 40%
UF University Research Foundation: 1 patents #17 of 49Top 35%
📍 Salt Lake City, UT: #590 of 4,590 inventorsTop 15%
🗺 Utah: #2,564 of 19,430 inventorsTop 15%
Overall (All Time): #656,971 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
7763580 Methods for treating conditions associated with the accumulation of excess extracellular matrix Nancy A. Noble 2010-07-27
7713924 Methods for treating conditions associated with the accumulation of excess extracellular matrix Nancy A. Noble, Daniel A. Lawrence 2010-05-11
7214375 Methods of decreasing the accumulation of extracellular matrix associated with glomerulonephritis with anti-TGF-β-specific antibodies Erkki Ruoslahti 2007-05-08
6906026 Methods for treating conditions associated with the accumulation of excess extracellular matrix Nancy A. Noble 2005-06-14
6509314 Methods of preventing or reducing scarring with decorin or biglycan Erkki Ruoslahti 2003-01-21
6316258 Methods for preventing and treating fibrotic diseases resulting from accumulation of excess extracellular matrix induced by TGF.beta. using renin inhibitors Nancy A. Noble 2001-11-13
5824655 Anti-transforming growth factor-.beta. gene therapy 1998-10-20
5726149 Treatment of glomerulonephritis with decorin Erkki Ruoslahti, Yu YAMAGUCHI 1998-03-10